Study Questions Claims of Reduced Harm from Heated Tobacco Products

Nov.14.2022
Study Questions Claims of Reduced Harm from Heated Tobacco Products
New study warns of lack of convincing evidence for reduced harm from heated tobacco products (HTP), urging caution in policymaking.

The author of a new study published in "Tobacco Control" stated that the existing evidence regarding heated tobacco products (HTP) is not convincing and policymakers should be cautious about claims of their harm reduction capabilities.


In recent years, there has been growing popularity of HTP, with supporters insisting that they pose less harm to health than traditional cigarettes. However, researchers at the University of Bath suggest that the evidence supporting these claims is largely not representative of real-world use and carries a high risk of bias.


Researchers analyzing 40 publicly available HTP (heated tobacco product) clinical trials, 29 of which were affiliated or funded by the tobacco industry, have determined that the majority of these trials carry a high risk of bias due to the methods and study designs chosen.


The most common reason for the high risk of bias in research is performance bias, where both the participants and those conducting the tests are aware of the assigned intervention measures. There is also a lack of reporting all data for all trial measurements, known as selective reporting bias.


The author believes that the presence of these biases could undermine the validity of the experiment and potentially lead to an overestimation of the effects of HTP. Additionally, they identified further limitations within the experiment, including short duration, restrictive conditions that do not reflect real-life situations, and a lack of relevant comparators such as e-cigarettes.


The tobacco control research group in Bath has stated that more detailed independent research is necessary to evaluate the short and long-term health impacts of HTP.


At the same time, they believe that consumers should be cautious of claims that reduce harm, and that policy makers and regulatory agencies should carefully consider the usefulness of these trials when making decisions regarding HTP.


In recent years, we have seen a significant expansion of the heated tobacco market in the UK and around the world. This growth is based on a marketing campaign that promotes these products as being healthier than traditional cigarettes," said Sophie Braznell, Chief Researcher at the Bath Department of Health.


Our analysis indicates that the situation is far from clear. Clinical trials that the tobacco industry uses to substantiate these claims are often inadequate in terms of study design and reporting, and most are somehow connected to the industry.


As more and more consumers switch from cigarettes to these new generation products, we need better evidence to evaluate their current and future health impacts. Meanwhile, the jury remains very attentive to their interests.


The research findings related to clinical trials of heated tobacco products are significant, and we need to be cautious about health claims," said Gemma Taylor, co-author of the study and member of the Addiction and Mental Health Group and Psychology Department at the University of Bath.


However, it is important to note the clear distinction between "heated tobacco products" and "electronic cigarettes." Consumers and health policymakers must not equate the potential benefits of electronic cigarettes in assisting people to quit smoking with heated tobacco products.


Statement:


This article is compiled from third-party information and is only intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of the content. The translation of this article is only for industry exchange and research.


Due to limitations in the translator's ability, the translated article may not accurately convey the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
A South Korean lawmaker has asked China’s tobacco regulator to clarify rules for e-cigarettes containing synthetic nicotine amid questions over product declarations and possible tax losses. The dispute exposes gaps between Chinese export requirements and destination-market rules, while underscoring the global impact of China’s licensing and traceability policies.
Jul.10
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
South Korea’s Cigarette Smoking Rate Falls to 17.9%, E-Cigarette Use Continues to Rise
Data released by the Korea Disease Control and Prevention Agency (KDCA) showed South Korea’s conventional cigarette smoking rate fell to 17.9% in 2025, while heated tobacco and liquid e-cigarette use continued to rise, particularly among young adults and women.
Jun.01
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04
Adani’s Mumbai Airport Duty-Free Shops Face Scrutiny Over Nicotine Pouch Sales in India
Adani’s Mumbai Airport Duty-Free Shops Face Scrutiny Over Nicotine Pouch Sales in India
An Indian investigation found that duty-free shops at Mumbai international airport operated by billionaire Gautam Adani’s business group sold nicotine pouches in breach of the law, Reuters reported, in a case that could shape how India regulates sales of new nicotine products at airport retail outlets.
Jul.08
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
French Vape Distributor Kumulus Vape Yields About 3% as Earnings Growth Stalls
Listed French vape distributor Kumulus Vape will trade ex-dividend on June 26, 2026, and pay an annual dividend of €0.10 per share on June 30, with Simply Wall St saying the payout is covered by profit and free cash flow, while weak earnings growth remains a concern.
Industry InsightMarketNews
Jun.24
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17